Featured Job
-
Job Removed or Not Found
Related Jobs
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree preferred 12+ years of experience including progressively responsible experience within sales, brand management/marketing
- Merck & Co. (North Wales, PA)
- …our Company we are leveraging analytics and technology, as we invent for life on behalf of patients around the world. We are seeking those who have a passion for using
- Lundbeck (Philadelphia, PA)
- …skills, competencies and proficiency for the role. Salary Pay Range: $ 200,000 - $230,000 and eligibility for a 20 % bonus target based on company and individual
- Catalent (PA)
- …are expected from the Proposal Lead I role:This is a full-time position, Monday - Friday, 9am - 5pm.Catalent is committed to a Patient First culture through excellence in
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree in Business, Diagnostic/Precision Health, or a related field preferred 12+ years of experience, including demonstrated
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree preferred 15+ years of experience, including demonstrated history in product strategy and marketing required Strong
- Merck & Co. (North Wales, PA)
- …(SPD) of your separation package, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree preferred 15+ years of experience, including a demonstrated history in early commercialization strategy or related roles
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Our focus extends beyond transactions to craft experiences as one fully integrated, aligned and connected organization that puts empathy at the center, powered by insight
- Catalent (St. Petersburg, FL)
- …Catalent is a global, high-growth, public company, and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for